XENE
$36.50+1.53%
Xenon Pharmaceuticals Inc.Stock · HealthcareRussell 2000 · 0.2% of IWMNasdaq Composite · 0.01% of ONEQRussell 3000 · 0.008% of IWV
Xenon Pharmaceuticals Inc. monthly returns
Xenon Pharmaceuticals Inc. has averaged 1.76% per month, positive in 48% of months. Month-by-month returns for Xenon Pharmaceuticals Inc. (XENE) below, through October 22, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Average month
+1.8%
142 months
Best month
+103.9%
Oct 2021
Worst month
-50.3%
Mar 2017
Positive months
48%
of all months
Xenon Pharmaceuticals Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -1.9% | |
| Sep 2026 | -38.2% | |
| Aug 2026 | -3.9% | |
| Jul 2026 | +3.8% | |
| Jun 2026 | +10.3% | |
| May 2026 | -2.3% | |
| Apr 2026 | -3.6% | |
| Mar 2026 | +34.5% | |
| Feb 2026 | +5.4% | |
| Jan 2026 | -8.5% | |
| Dec 2025 | +0.2% | |
| Nov 2025 | +6.7% | |
| Oct 2025 | +4.4% | |
| Sep 2025 | +3.7% | |
| Aug 2025 | +26.8% | |
| Jul 2025 | -2.4% | |
| Jun 2025 | +8.5% | |
| May 2025 | -24.5% | |
| Apr 2025 | +13.9% | |
| Mar 2025 | -9.4% | |
| Feb 2025 | -7.4% | |
| Jan 2025 | +2.0% | |
| Dec 2024 | -8.0% | |
| Nov 2024 | +3.7% | |
| Oct 2024 | +4.4% | |
| Sep 2024 | -2.4% | |
| Aug 2024 | -6.5% | |
| Jul 2024 | +10.6% | |
| Jun 2024 | +2.4% | |
| May 2024 | -6.3% | |
| Apr 2024 | -5.6% | |
| Mar 2024 | -8.8% | |
| Feb 2024 | +4.4% | |
| Jan 2024 | -1.8% | |
| Dec 2023 | +25.9% | |
| Nov 2023 | +18.0% | |
| Oct 2023 | -9.3% | |
| Sep 2023 | -12.4% | |
| Aug 2023 | +5.6% | |
| Jul 2023 | -4.1% | |
| Jun 2023 | -0.1% | |
| May 2023 | -4.3% | |
| Apr 2023 | +12.5% | |
| Mar 2023 | -9.3% | |
| Feb 2023 | +0.9% | |
| Jan 2023 | -0.9% | |
| Dec 2022 | +6.9% | |
| Nov 2022 | +0.8% | |
| Oct 2022 | +1.3% | |
| Sep 2022 | -7.0% | |
| Aug 2022 | +17.1% | |
| Jul 2022 | +9.0% | |
| Jun 2022 | +15.4% | |
| May 2022 | -6.8% | |
| Apr 2022 | -7.5% | |
| Mar 2022 | -3.6% | |
| Feb 2022 | +16.9% | |
| Jan 2022 | -13.2% | |
| Dec 2021 | +17.0% | |
| Nov 2021 | -14.3% | |
| Oct 2021 | +103.9% | |
| Sep 2021 | -13.4% | |
| Aug 2021 | +2.2% | |
| Jul 2021 | -7.3% | |
| Jun 2021 | +0.8% | |
| May 2021 | +0.8% | |
| Apr 2021 | +2.3% | |
| Mar 2021 | -4.2% | |
| Feb 2021 | +30.2% | |
| Jan 2021 | -6.7% | |
| Dec 2020 | +29.4% | |
| Nov 2020 | +22.3% | |
| Oct 2020 | -12.2% | |
| Sep 2020 | -8.9% | |
| Aug 2020 | +11.2% | |
| Jul 2020 | -12.8% | |
| Jun 2020 | -8.5% | |
| May 2020 | +5.7% | |
| Apr 2020 | +14.3% | |
| Mar 2020 | -21.4% | |
| Feb 2020 | -1.5% | |
| Jan 2020 | +11.7% | |
| Dec 2019 | +10.8% | |
| Nov 2019 | +38.5% | |
| Oct 2019 | -5.2% | |
| Sep 2019 | -3.3% | |
| Aug 2019 | -3.1% | |
| Jul 2019 | -2.4% | |
| Jun 2019 | -2.4% | |
| May 2019 | +8.7% | |
| Apr 2019 | -8.6% | |
| Mar 2019 | +10.7% | |
| Feb 2019 | +7.5% | |
| Jan 2019 | +35.3% | |
| Dec 2018 | -25.1% | |
| Nov 2018 | -16.8% | |
| Oct 2018 | -23.3% | |
| Sep 2018 | -0.4% | |
| Aug 2018 | +33.2% | |
| Jul 2018 | +8.2% | |
| Jun 2018 | +64.3% | |
| May 2018 | -8.2% | |
| Apr 2018 | +24.5% | |
| Mar 2018 | +30.7% | |
| Feb 2018 | +17.2% | |
| Jan 2018 | +13.3% | |
| Dec 2017 | +15.3% | |
| Nov 2017 | -21.0% | |
| Oct 2017 | +5.1% | |
| Sep 2017 | -6.3% | |
| Aug 2017 | +1.6% | |
| Jul 2017 | -1.6% | |
| Jun 2017 | -13.7% | |
| May 2017 | -7.6% | |
| Apr 2017 | -1.3% | |
| Mar 2017 | -50.3% | |
| Feb 2017 | -1.8% | |
| Jan 2017 | +6.5% | |
| Dec 2016 | -1.3% | |
| Nov 2016 | +2.6% |
Monthly total return (since Nov 2021)#
-20%0%20%
Nov 2021-14%
Dec 2021+17%
Jan 2022-13%2022
Feb 2022+17%
Mar 2022-3.6%
Apr 2022-7.5%
May 2022-6.8%
Jun 2022+15%
Jul 2022+9.0%
Aug 2022+17%
Sep 2022-7.0%
Oct 2022+1.3%
Nov 2022+0.85%
Dec 2022+6.9%
Jan 2023-0.86%2023
Feb 2023+0.95%
Mar 2023-9.3%
Apr 2023+13%
May 2023-4.3%
Jun 2023-0.08%
Jul 2023-4.1%
Aug 2023+5.6%
Sep 2023-12%
Oct 2023-9.3%
Nov 2023+18%
Dec 2023+26%
Jan 2024-1.8%2024
Feb 2024+4.4%
Mar 2024-8.8%
Apr 2024-5.6%
May 2024-6.3%
Jun 2024+2.4%
Jul 2024+11%
Aug 2024-6.5%
Sep 2024-2.4%
Oct 2024+4.4%
Nov 2024+3.7%
Dec 2024-8.0%
Jan 2025+2.0%2025
Feb 2025-7.4%
Mar 2025-9.4%
Apr 2025+14%
May 2025-24%
Jun 2025+8.5%
Jul 2025-2.4%
Aug 2025+27%
Sep 2025+3.7%
Oct 2025+4.4%
Nov 2025+6.7%
Dec 2025+0.22%
Jan 2026-8.5%2026
Feb 2026+5.4%
Mar 2026+35%
Apr 2026-3.6%
May 2026-2.3%
Jun 2026+10%
Jul 2026+3.8%
Aug 2026-3.9%
Sep 2026-38%
Oct 2026-1.9%
Xenon Pharmaceuticals Inc. returns by calendar month#
Every month of every year since 2015, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -1.86% — 6th of 12 Octobers since 2015 at the last close; the average October returned +5.5%.
| Month | −105%0+105% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +0.8% | -1.3% | 42% | +35.3% 2019 | -17.8% 2016 | |
| Feb | +7.6% | +6.5% | 75% | +30.2% 2021 | -7.4% 2025 | |
| Mar | -4.0% | -6.7% | 25% | +34.5% 2026 | -50.3% 2017 | |
| Apr | +1.8% | +0.4% | 50% | +24.5% 2018 | -21.4% 2015 | |
| May | -3.6% | -3.6% | 33% | +8.7% 2019 | -24.5% 2025 | |
| Jun | +3.8% | +0.4% | 50% | +64.3% 2018 | -16.4% 2015 | |
| Jul | +2.1% | -2.0% | 42% | +29.5% 2016 | -12.8% 2020 | |
| Aug | +6.6% | +3.3% | 67% | +33.2% 2018 | -9.8% 2015 | |
| Sep | -8.6% | -6.7% | 17% | +3.7% 2025 | -38.2% 2026 | |
| Oct | +5.5% | -2.5% | 45% | +103.9% 2021 | -23.3% 2018 | |
| Nov | +5.0% | +3.7% | 73% | +38.5% 2019 | -21.0% 2017 | |
| Dec | +5.3% | +6.9% | 64% | +29.4% 2020 | -25.1% 2018 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from XENE's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Xenon Pharmaceuticals Inc.'s average monthly return?
- Xenon Pharmaceuticals Inc. (XENE) has averaged about 1.76% per month, positive in roughly 48% of months. The best month was Oct 2021 (+103.9%) and the worst was Mar 2017 (-50.3%).
More on Xenon Pharmaceuticals Inc.
By month for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100